10- 144 C.M.R. ch. 709, § 9.0

Current through 2024-46, November 13, 2024
Section 144-709-9.0 - SCREENING TEST PERFORMED
9.1 Screening for CCHD shall be performed by pulse oximetry using equipment approved for neonatal use by the FDA. See (http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm).
9.2 Screening is performed in the right hand and either foot. Screening can occur concurrently or sequentially.

10- 144 C.M.R. ch. 709, § 9.0